Healthcare on the brink: navigating the challenges of an aging society in the United States
Charles H. Jones, Mikael Dolsten · npj Aging · 2024 · Review
Full textCC BY
Economics and Econometrics
Filters2 filters applied
Status
Year
Study type
Licence
28 papers1 CorrectedQuestions on this topic
Corrected Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
Simiao Chen, Zhong Cao, Klaus Prettner et al. · JAMA Oncology · 2023
Full textCC BY
The cost-effectiveness of digital health interventions: A systematic review of the literature
Andrea Gentili, Giovanna Failla, Andriy Melnyk et al. · Frontiers in Public Health · 2022 · Systematic review
Full textCC BY
The Out-of-Pocket Cost Burden of Cancer Care—A Systematic Literature Review
Nicolas Iragorri, Claire de Oliveira, Natalie Fitzgerald et al. · Current Oncology · 2021 · Systematic review
Full textCC BY
Economic Consequences of the COVID-19 Outbreak: the Need for Epidemic Preparedness
Anton Pak, Oyelola A. Adegboye, Adeshina I. Adekunle et al. · Frontiers in Public Health · 2020
Full textCC BY
Financial toxicity and employment status in cancer survivors. A systematic literature review
Floortje Mols, Bianca Tomalin, Alison Pearce et al. · Supportive Care in Cancer · 2020 · Systematic review
Full textCC BY
US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples
Ruixuan Jiang, M. F. Bas Janssen, A. Simon Pickard · Quality of Life Research · 2020
Full textCC BY
Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies
Ashley A. Leech, David D. Kim, Joshua T. Cohen et al. · Value in Health · 2018
Full textCC BY
Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013
Alessandro Cassini, Edoardo Colzani, Alessandro Pini et al. · Eurosurveillance · 2018
Full textCC BY
Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020
Sachiko Ozawa, Samantha Clark, Allison Portnoy et al. · Bulletin of the World Health Organization · 2017
Full textCC BY
The scope and impact of mobile health clinics in the United States: a literature review
Stephanie W. Y. Yu, Caterina Hill, Mariesa L. Ricks et al. · International Journal for Equity in Health · 2017 · Review
Full textCC BY
Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries
The ACTION Study Group · BMC Medicine · 2015
Full textCC BY
Vaccination: the cornerstone of an efficient healthcare system
Vanessa Rémy, York Zöllner, Ulrike Heckmann · Journal of Market Access & Health Policy · 2015
Full textCC BY
Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
Wills Hughes-Wilson, Ana Palma, Ad Schuurman et al. · Orphanet Journal of Rare Diseases · 2012
Full textCC BY
From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking
Lalla Aïda Guindo, Monika Wagner, Rob Baltussen et al. · Cost Effectiveness and Resource Allocation · 2012 · Review
Full textCC BY
A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments
Melanie Wyld, Rachael Lisa Morton, Andrew Hayen et al. · PLoS Medicine · 2012 · Meta-analysis
Full textCC BY
Does Hospital Competition Save Lives? Evidence from the English NHS Patient Choice Reforms
Zack Cooper, Stephen Gibbons, Simon Jones et al. · The Economic Journal · 2011
Full textCC BY
The impact of universal National Health Insurance on population health: the experience of Taiwan
Yue-Chune Lee, Yu-Tung Huang, Yi-Wen Tsai et al. · BMC Health Services Research · 2010
Full textCC BY
Food consumption trends and drivers
John Kearney · Philosophical Transactions of the Royal Society B: Biological Sciences · 2010 · Review
Full textCC BY
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
Jakub Adamski, Brian Godman, Gabriella Ofierska-Sujkowska et al. · BMC Health Services Research · 2010 · Review
Full textCC BY